Barclays’s MEDASSETS INC COM STK (DE) MDAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-11,486
| Closed | -$345K | – | 6823 |
|
|
2015
Q4 | $345K | Buy |
11,486
+11,096
| +2,845% | +$308K | ﹤0.01% | 3494 |
|
|
2015
Q3 | $8K | Sell |
390
-766
| -66% | -$16.3K | ﹤0.01% | 5896 |
|
|
2015
Q2 | $26K | Sell |
1,156
-132,491
| -99% | -$2.76M | ﹤0.01% | 5538 |
|
|
2015
Q1 | $2.41M | Buy |
133,647
+130,175
| +3,749% | +$2.48M | ﹤0.01% | 2142 |
|
|
2014
Q4 | $66K | Buy |
3,472
+1,359
| +64% | +$27.6K | ﹤0.01% | 5499 |
|
|
2014
Q3 | $42K | Buy |
2,113
+61
| +3% | +$1.36K | ﹤0.01% | 6018 |
|
|
2014
Q2 | $44K | Sell |
2,052
-2,813
| -58% | -$65.8K | ﹤0.01% | 6046 |
|
|
2014
Q1 | $116K | Sell |
4,865
-4,057
| -45% | -$91.4K | ﹤0.01% | 5312 |
|
|
2013
Q4 | $170K | Sell |
8,922
-1,919
| -18% | -$43.1K | ﹤0.01% | 5168 |
|
|
2013
Q3 | $271K | Buy |
10,841
+5,042
| +87% | +$113K | ﹤0.01% | 4748 |
|
|
2013
Q2 | $103K | Buy |
+5,799
| New | +$104K | ﹤0.01% | 5766 |
|
Barclays's MDAS Position: Q1 2016 in Review
Barclays sold out of MEDASSETS INC COM STK (DE) (MDAS) in Q1 2016, closing a stake of 11,486 shares — an estimated $345K sold.
Barclays first reported a position in MDAS in Q2 2013 and held it in 11 quarters. The position peaked at $2.41M in Q1 2015. 0 funds tracked by Wall St. Rank hold MDAS as of Q1 2016.
- Barclays reported no remaining MEDASSETS INC COM STK (DE) position as of Q1 2016 after selling out during the quarter.
- Barclays sold 11,486 MEDASSETS INC COM STK (DE) shares in Q1 2016, an estimated $345K.
- Barclays first reported a position in MEDASSETS INC COM STK (DE) in Q2 2013 and held it in 11 quarters.
- Barclays's MEDASSETS INC COM STK (DE) position peaked at $2.41M in Q1 2015.
- 0 funds tracked by Wall St. Rank held MEDASSETS INC COM STK (DE) as of Q1 2016.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.